Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Coronary thrombosis
MeSH D003328 - coronary thrombosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D003327:
Coronary disease
49 Companies
6 Drugs
$
Success rate
D013927:
Thrombosis
8 Companies
1 Drug
$
Success rate
D003328:
Coronary thrombosis
34 Companies
6 Drugs
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
100
%
3/3
Approved:
3
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Boehringer Ingelheim
Tenecteplase
Aspen Global
Heparin
,
Heparin sodium
Novartis
Dihydroergotamine
,
Heparin
,
Heparin sodium
,
Lidocaine
Sanofi
Heparin
,
Heparin sodium
Pfizer
Heparin
,
Heparin sodium
Eli Lilly
Heparin
,
Heparin sodium
Genentech
Tenecteplase
Fresenius Kabi
Heparin
,
Heparin sodium
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use